Literature DB >> 3398799

Comparison of Reflotron and laboratory cholesterol measurements.

S Kinlay1.   

Abstract

Fifty-three patients from a general practice and 33 subjects who were in a community-screening promotion underwent total cholesterol level measurements both with a portable Reflotron system and by a standardized laboratory procedure. The intraclass correlation coefficient between the paired measurements was equal to 0.956; this suggests that the results of the Reflotron system agreed very closely with those of the laboratory procedure. In spite of this agreement, the Reflotron instrument, on average, gave lower results than did the laboratory procedure (mean difference, -0.164 mmol/L; 95% confidence interval, -0.094 to -0.234 mmol/L). This difference is small and, in comparison with other sources of variation in cholesterol measurement, is unlikely to be important in day-to-day clinical practice. However, the difference between the two methods appeared to be related to the cholesterol level (larger differences at lower cholesterol levels). In large studies, where small differences in cholesterol levels are important, this difference should be considered against the obvious convenience of rapid portable cholesterol measurements.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3398799     DOI: 10.5694/j.1326-5377.1988.tb120534.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  3 in total

1.  Reflotron measurement of blood cholesterol.

Authors:  F A Majeed
Journal:  Br J Gen Pract       Date:  1992-01       Impact factor: 5.386

2.  Cardiovascular risk screening program in Australian community pharmacies.

Authors:  Gregory M Peterson; Kimbra D Fitzmaurice; Helen Kruup; Shane L Jackson; Rohan L Rasiah
Journal:  Pharm World Sci       Date:  2010-03-10

3.  Comparison of the use of a dry chemistry analyser in primary care in Norway and the United Kingdom.

Authors:  G Thue; S Sandberg; D G Bullock
Journal:  Br J Gen Pract       Date:  1993-01       Impact factor: 5.386

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.